Market capitalization | $37.88b |
Enterprise Value | $45.24b |
P/E (TTM) P/E ratio | 22.71 |
EV/FCF (TTM) EV/FCF | 26.69 |
EV/Sales (TTM) EV/Sales | 2.31 |
P/S ratio (TTM) P/S ratio | 1.94 |
P/B ratio (TTM) P/B ratio | 4.55 |
Dividend yield | 0.14% |
Last dividend (FY24) | $0.12 |
Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.
20 Analysts have issued a GE HealthCare Technologies forecast:
20 Analysts have issued a GE HealthCare Technologies forecast:
Sep '24 |
+/-
%
|
||
Revenue | 19,558 19,558 |
1%
1%
|
|
Gross Profit | 8,100 8,100 |
7%
7%
|
|
EBITDA | 3,432 3,432 |
12%
12%
|
EBIT (Operating Income) EBIT | 2,847 2,847 |
17%
17%
|
Net Profit | 1,676 1,676 |
3%
3%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
GE Healthcare Technologies, Inc. operates as a holding company with interest in providing medical technology, pharmaceutical diagnostics and digital solutions. Its operating segments include Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment provides scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment offers screening, diagnosis, treatment and monitoring of certain diseases. The Patient Care Solutions segment specializes in providing medical devices, consumables, services and digital solutions. The Pharmaceutical Diagnostics segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company was founded on May 16, 2022 and is headquartered in Chicago, IL.
Head office | United States |
CEO | Peter Arduini |
Employees | 51,000 |
Founded | 2022 |
Website | www.gehealthcare.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.